Clinical trials
Spondylitis, Ankylosing trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charite University, Berlin, Germany | 8 |
| Chengdu PLA General Hospital | 2 |
| Chung Shan Medical University | 2 |
| Gazi University | 2 |
| Rheumazentrum Ruhrgebiet | 2 |
| Sun Yat-sen University | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| Aalborg University Hospital | 1 |
| Ankara City Hospital Bilkent | 1 |
| Antalya Training and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spondylitis, Ankylosing | 81 |
| Arthritis, Rheumatoid | 21 |
| Arthritis, Psoriatic | 13 |
| Spondylarthritis | 10 |
| Axial Spondyloarthritis | 9 |
| Arthritis | 8 |
| Crohn Disease | 7 |
| Colitis, Ulcerative | 5 |
| Psoriasis | 4 |
| Spondylarthropathies | 4 |
Trials
Showing 26 to 50 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.